Arkolith/Insider Trading/CTMX/Form 4

McCarthy Sean A.

CEO, DirectorCytomX Therapeutics, Inc. (CTMX) · full profile →Form 4 · filed Mar 28, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2024Option exercise(M)110K$1.57$172K634K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2024Option exercise(M)110K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000190) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML